The 75 references in paper M. Pokrovsky V., V. Gureev V., E. Stupakova G., O. Antsiferova E., T. Lokteva I., L. Zhilinkova A., М. Покровский В., В. Гуреев В., Е. Ступакова Г., О. Анциферова Е., Т. Локтева И., Л. Жилинкова А. (2018) “Биологические механизмы естественной цитопротекции - перспективное направление создания новых лекарственных препаратов для профилактики и лечения преэклампсии // Biological mechanisms of natural cytoprotection - a promising trend in the development of new medicines aimed at prevention and treatment of preeclampsia” / spz:neicon:vedomostincesmp:y:2016:i:4:p:20-27

1
WHO.Maternalmortality.Newsletter¹ 348.May2012 http://www.who.int/mediacentre/factsheets/fs348/ru/index.html (in Russian).
(check this in PDF content)
2
Kolgushkina TN. Preeclampsia (etiopathogenesis, clinical picture, diagnosis, treatment): method. Recommendation. Minsk: MGMI; 2000.
(check this in PDF content)
3
Shuvalova MP, Frolova OG, Ratushnyak SS, Grebennik TK, Guseva EV. Pre-eclampsia and eclampsia as a cause of maternal mortality. Akusherstvo i ginekologiya 2014; (1): 81–7 (in Russian).
(check this in PDF content)
4
Reznikova LB. Endothelioprotective activity of GABA derivatives in experimental gestosis. Dr. Med. Sci [dissertation]. Volgograd; 2013 (in Russian).
(check this in PDF content)
5
TheFederalStateStatisticsService.Availablefrom: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/ statistics/population/healthcare/(in Russian).
(check this in PDF content)
6
Savelieva GM, Shalina RI, Panina OB, Kurtser MA. Obstetrics: a textbook. Moscow: GEOTAR Media; 2011 (in Russian).
(check this in PDF content)
7
Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 2014; (5): 372.
(check this in PDF content)
8
Scioscia M, Karumanchi SA, Goldman-Wohl D, Robillard PY. Endothelial dysfunction and metabolic syndrome in preeclampsia: analternativeviewpoint.JReprodImmunol.2015.pii: S0165–0378(15)00027–3. doi: 10.1016/j.jri.2015.01.009.
(check this in PDF content)
9
Zainulina MS. Endothelial dysfunction and its markers in preeclampsia. Zhurnal akusherstva i zhenskih bolezney 1997; (3): 18–22 (in Russian).
(check this in PDF content)
10
Gureev VV. Endothelial dysfunction — a central element in the pathogenesis of preeclampsia. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta 2012; 4(123): 5–12 (in Russian).
(check this in PDF content)
11
Bloschinskaya IA. The functional state of the vascular endothelium and microcirculation disorders in pregnancy complicated by preeclampsia and the effects of normobaric hypoxic therapy. Dr. Med. Sci [dissertation]. Khabarovsk: 2003 (in Russian).
(check this in PDF content)
12
Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the Placenta: The Role of Reactive Oxygen SpeciesSignaling.BiomedResInt.2015;2015:814543.doi: 10.1155/2015/814543.
(check this in PDF content)
13
Verlohren S, Geusens N, Morton J, Verhaegen I, Hering L, Herse F, et al. Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 2010; 56(2): 304–10.
(check this in PDF content)
14
Ducray JF, Naicker T, Moodley J. Pilot study of comparative placental morphometry in pre-eclamptic and normotensive pregnancies suggests possible maladaptations of the fetal component of the placenta. Eur J Obstet Gynecol Reprod Biol. 2011; 156(1): 29–34.
(check this in PDF content)
15
Oppenraaij RHF, Bergen NE, Duvekot JJ, de Krijger RR, Hop Ir WCJ, Steegers EAP, et al. Placental vascularization in early onset small for gestational age and preeclampsia. Reprod Sci. 2011; 18(6): 586–93.
(check this in PDF content)
16
Wang QJ, Song BF, Zhang YH, Ma YY, Shao QQ, Liu J, et al. Expression of RGC32 in human normal and preeclamptic placentas and its role in trophoblast cell invasion and migration. Placenta 2015; 36(4): 350–6.
(check this in PDF content)
17
Bloschinskaya IA. The role of the main vasoactive factors of the vascular endothelium in the development of preeclampsia. Rossiyskiy vestnik akushera-ginekologa 2003; (4): 7–10 (in Russian).
(check this in PDF content)
18
Sidorova IS. Preeclampsia. Moscow: Meditsina; 2003 (in Russian).
(check this in PDF content)
19
Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecher K. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol Obstet Invest. 2010; 69(1): 1–13.
(check this in PDF content)
20
Alpoim PN, Godoi LC, Freitas LG, Gomes KB, Dusse LM. Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide 2013; (1): 81–2.
(check this in PDF content)
21
Augustine MS, Rogers LK. Measurement of arginine metabolites: regulators of nitric oxide metabolism. Curr Protoc Toxicol. 2013. doi: 10.1002/0471140856.tx1716s58.
(check this in PDF content)
22
Noorbakhsh M, Kianpour M, Nematbakhsh M. Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstet Gynecol. 2013. doi: 10.1155/2013/104213.
(check this in PDF content)
23
Laskowska M, Laskowska K, Oleszczuk J. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. J Matern Fetal Neonatal Med. 2015; 28(1): 26–32.
(check this in PDF content)
24
Micle O, Muresan M, Antal L. The influence of homocysteine and oxidative stress on pregnancy outcome. J Med Life 2012; 5(1): 68–73.
(check this in PDF content)
25
Krukier II. The processes of radical formation in the placenta during placental insufficiency. Rossiyskiy vestnik akushera-ginekologa 2004; (4): 6–8 (in Russian).
(check this in PDF content)
26
Khetsuriani T. Role of oxygenic stress ands1-receptors in the development of pre-eclampsia and its pathogenetic treatment. Dr. Med. Sci [thesis]. Tbilisi; 2006 (in Russian).
(check this in PDF content)
27
Bouras G, Deftereos S, Tousoulis D, Giannopoulos G, Chatzis G, Tsounis D, et al. Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease? Curr Top Med Chem. 2013; 13(2): 180–200.
(check this in PDF content)
28
Yi-Ping Leng, Ni Qiu, Wei-jin Fang, Mei Zhang, Zhi-Min He. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats. doi: 10.1371/journal.pone.0097125.
(check this in PDF content)
29
Ariza AC,BobadillaNA, Halhali A. Endothelin 1 and angiotensin II in preeclampsia. Rev Invest Clin. 2007; 59(1): 48–56.
(check this in PDF content)
30
Guibourdenche J, Leguy MC, Tsatsaris V. Biology and markers of preeclampsia. Ann Biol Clin. 2013; 71: 79–87.
(check this in PDF content)
31
Blois SM, Dechend R, Barrientos G, Staff AC. A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia. Cell Mol Life Sci. 2015; 72(1): 39–50.
(check this in PDF content)
32
Thomason J, Reyes M, Allen SR, Jones RO, Beeram MR, Kuehl TJ, et al. Elevation of (Pro)Renin and (Pro)Renin Receptor in Preeclampsia. Am J Hypertens. 2015; 28(10): 1277–84.
(check this in PDF content)
33
Wang J, Cui Y, Ge J, Ma M. Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats. Neural Regen Res. 2012; 7(25): 1954–9.
(check this in PDF content)
34
Pérez-Sepúlveda A, España-Perrot PP, Fernández XB, Ahumada V, Bustos V, Arraztoa JA, et al. Levels of key enzymes of methionine-homocysteine metabolism in preeclampsia. Biomed Res Int. 2013. 2013:731962. doi: 10.1155/2013/731962.
(check this in PDF content)
35
Powers RW, Gandley RE, Lykins DL, Roberts JM. Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice. Hypertension 2004; 44: 327–33.
(check this in PDF content)
36
Shcherbakova ES, Dunaeva AR, Zagidullin NSh. Ischemic preconditioning in internal medicine and vascular surgery. Meditsinskiy vestnik Bashkortostana 2014; 9(1): 118–23 (in Russian).
(check this in PDF content)
37
Karpov ES, Kotelnikova EV, Lyamina NP. Ischemic preconditioning and its cardioprotective effect in patients with cardio-rehabilitation programs with coronary heart disease after percutaneous coronary intervention. Rossiyskiy kardiologicheskiy zhurnal 2012; 4(96): 104–8 (in Russian).
(check this in PDF content)
38
Griecsová L, Farkašová V, Gáblovský I, Khandelwal VK, Bernátová I, TatarkováZ, et al. Effect of maturation on the resistance of rat hearts against ischemia. Study of potential molecular mechanisms. Physiol Res 2015 Dec 15. [Epub ahead of print].
(check this in PDF content)
39
Morris CF, Tahir Ì, Arshid S, Castro MS, Fontes W. Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res. 2015. doi: 10.1155/2015/697193.
(check this in PDF content)
40
Alleman RJ, Stewart LM, Tsang AM, Brown DA. Why Does Exercise «Trigger» Adaptive Protective Responses in the Heart? Dose Response. 2015 Jan-Mar; 13(1). doi: 10.2203/dose-response.14–023.Alleman
(check this in PDF content)
41
Veighey K, Macallister RJ. Clinical applications of remote ischemic preconditioning. Cardiol Res Pract. 2012. 2012:620681. doi: 10.1155/2012/620681.
(check this in PDF content)
42
Kocman EA, Ozatik O, Sahin A, Guney T, Kose AA, Dag I, et al. Effects of ischemic preconditioning protocols on skeletal muscle ischemia-reperfusion injury. J Surg Res. 2015; 193(2): 942–52.
(check this in PDF content)
43
Lanza GA, Stazi A, Villano A, Torrini F, Milo M, Laurito M. Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures. Am J Cardiol. 2016; 117(3): 359–65.
(check this in PDF content)
44
Kierulf-Lassen Ñ, Kristensen ML, Birn H, Jespersen B, Nørregaard R. No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators. PLoS One. 2015 Dec 31; 10(12): e0146109. doi: 10.1371/journal.pone.0146109. eCollection 2015.
(check this in PDF content)
45
Damous LL, da Silva SM, Carbonel AA, Simões MJ, Baracat EC, Montero EF. Progressive Evaluation of Apoptosis, Proliferation, and Angiogenesis in Fresh Rat Ovarian Autografts Under Remote Ischemic Preconditioning. Reprod Sci. 2015 Dec 16. pii: 1933719115620493. [Epub ahead of print].
(check this in PDF content)
46
Deng QW, Xia ZQ, Qiu YX, Wu Y, Liu JX, Li C, et al. Clinical benefits of aortic cross-clamping versus limb remote ischemic preconditioning in coronary artery bypass grafting with cardiopulmonary bypass: a meta-analysis of randomized controlled trials. J Surg Res. 2015; 193(1): 52–68.
(check this in PDF content)
47
Bautin AE, Galagudza MM, Datsenko SV, Tashkhanov DM, Marichev AO, Bakanov AU, et al. Effect of ischemic preconditioning on the distant during the perioperative period in isolated aortic valve replacement. Anestesiologiya i reanimatologiya 2014; (3): 11–7 (in Russian).
(check this in PDF content)
48
Gallyamov NV. Ischemic preconditioning and remote ischemic preconditioning in healthy subjects and patients with stable angina, and their effect on platelet aggregation. Dr. Med. Sci [dissertation]. Kazan; 2009 (in Russian).
(check this in PDF content)
49
Maslov LN, Kolar F, Krig T. Distant ischemic preconditioning. Uspehi fiziologicheskih nauk 2009; (4): 64–78 (in Russian).
(check this in PDF content)
50
Björnsson B, Winbladh A, Bojmar L, Sundqvist T, Gullstrand P, Sandström P. Conventional, but not remote ischemic preconditioning, reduces iNOS transcription in liver ischemia/reperfusion. World J Gastroenterol. 2014; 20(28): 9506–12.
(check this in PDF content)
51
Morris CFM, Tahir M, Arshid S, Castro MS, Fontes W. Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res. 2015. doi: 10.1155/2015/697193.
(check this in PDF content)
52
Sandanger O, Gao E, Ranheim T, Bliksoen M, Kaasboll OJ, Alfsnes K, et al. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective. Biochem Biophys Res Commun. 2016; 469(4): 1012–20.
(check this in PDF content)
53
Johnsen J, Pryds K, Salman R, Lofgren B, Kristiansen SB, Botker HE. The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection. Basic Res Cardiol 2016; 111(2): 10.
(check this in PDF content)
54
Naryzhnaya NV, Maslov LN, Vychuzhanova EA, Sementsov AS, Podoksenov YuK, Portnichenko AG, et al. Effect of hypoxic preconditioningon theindicatorsof stress reaction in rats. Bulleten eksperimentalnoy biologii i meditsiny 2015; 159(4): 439 (in Russian).
(check this in PDF content)
55
Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, et al. Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote Impact): a randomized controlled trial. CMAJ 2015; 313(21): 2133–41.
(check this in PDF content)
56
Saxena S, Shukla D, Bansal A. Expression of Monocarboxylate Transporter Isoforms in Rat Skeletal Muscle Under Hypoxic Preconditioning and Endurance Training. High Alt Med Biol. 2015 Dec 30. [Epub ahead of print].
(check this in PDF content)
57
Zhao R, Feng J, He G. Hypoxia increases Nrf2-induced HO-1 expression via the PI3K/Akt pathway. Front Biosci (Landmark Ed) 2016; 21: 385–96.
(check this in PDF content)
58
Zhai X, Lin H, Chen Y, Chen X, Shi J, Chen O, et al. Hyperbaric oxygen preconditioning ameliorates hypoxia-ischemia brain damage by activating Nrf2 expression in vivo and in vitro. Free Radic Res. 2016; 4: 1–34.
(check this in PDF content)
59
Liu D, Liu X, Zhou T, Yao W, Zhao J, Zheng Z, et al. IRE1-RACK1 axis orchestrates ER stress preconditioning-elicited cytoprotection from ischemia/reperfusion injury in liver. J Mol Cell Biol. 2016; 8(2): 144–56.
(check this in PDF content)
60
Hong S, Ahn JY, Cho GS, Kim IH, Cho JH, Ahn JH, et al. Monocarboxylate transporter 4 plays a significant role in the neuroprotective mechanism of ischemic preconditioning in transient cerebral ischemia. Neural Regen Res. 2015; 10(10): 1604–11.
(check this in PDF content)
61
Zhang M, Gong JX, Wang JL, Jiang MY, Li L, Hu YY, et al. P38 MAPK Participates in the Mediation of GLT-1 Up-regulation During the Induction of Brain Ischemic Tolerance by Cerebral Ischemic Preconditioning. Mol Neurobiol. 2016 Jan 5. [Epub ahead of print].
(check this in PDF content)
62
Ji K, Xue L, Cheng J, Bai Y. Preconditioning of H2S inhalation protects against cerebral ischemia/reperfusion injury by induction of HSP70 through PI3K/Akt/Nrf2 pathway. Brain Res Bull. 2016; 121: 68–74.
(check this in PDF content)
63
Fang XZ, Huang TF, Wang CJ, Ge YL, Lin SY, Zhang Y. Preconditioning of physiological cyclic stretch attenuated HMGB1 expression in pathologically mechanical stretch-activated A549 cells and ventilator-induced lung injury rats through inhibition of IL-6/STAT3/SOCS3. Int Immunopharmacol. 2015; 31: 66–73.
(check this in PDF content)
64
Ávalos R, Martinez-Sanz R, JiménezJJ, Iribarren JL, Montoto J, Lacruz A, et al. Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results. J Cardiothorac Surg. 2015; 10(Suppl 1): A310. doi: 10.1186/1749–8090–10-S1-A310.
(check this in PDF content)
65
Behmenburg F, Dorsch M, Huhn R, Mally D, Heinen A, Hollmann MW. Impact of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats. PLoS One. 2015 Dec 15; 10(12): e0144737. doi: 10.1371/journal.pone.0144737.
(check this in PDF content)
66
Ansley DM, Raedschelders K, Choi PT, Wang B, Cook RC, Chen DD. Propofol cardioprotection for on-pump aortocoronary bypass surgery in patients with type 2 diabetes mellitus (PRO-TECT II): a phase 2 randomized-controlled trial. Can J Anaesth. 2016; 63(4): 442–5.
(check this in PDF content)
67
Li W, Jia D. Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats. Exp Ther Med. 2015; 10(6): 2197–205.
(check this in PDF content)
68
Gureev VV, Pokrovsky MV, Korokin MV, Pokrovskaya TG, Gudyrev OS, Kochkarev VI, et al. ADMA-eNOS-deterministic ways of pharmacological correction of preeclampsia. Belgorod: Izdatelstvo BelGU; 2014 (in Russian).
(check this in PDF content)
69
Gureev VV. Investigation of the role of ischemic preconditioning in the distant correction of morphological and functional disturbances by short episodes of ischemia-reperfusion in the condition of ADMA-like preeclampsia. Kursk scientific-practical bulletin «Chelovek i ego zdorovie» 2012; (3): 5–9 (in Russian).
(check this in PDF content)
70
Gureev VV. Inos role in the correction of endothelial dysfunction in preeclampsia ADMA-like short episodes of ischemia-reperfusion in the experiment. Fundamentalnye issledovaniya 2012; (8)2: 298–301 (in Russian).
(check this in PDF content)
71
Gureev VV. The role of ATP-sensitive K+channels in the correction of endothelial dysfunction in preeclampsia ADMA-like short episodes of ischemia-reperfusion in the experiment. Sovremennye problem nauki i obrazovaniya 2012; (5). Available from: http://www.science-education.ru/105-7053 (in Russian).
(check this in PDF content)
72
Gureev VV, Pokrovsky MV, Dolzhikov AA, Alekhin SA, Dolzhikova IN, Gureeva EG, et al. Correction of ischemic preconditioning distant endothelial dysfunction in ADMA-like experimental gestosis. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta 2012; 4(123): 128–34.
(check this in PDF content)
73
Gureev VV, Alehin SA, Pokrovskiy MV, Dolghikov AA, Korokin MV, Gudyrev OS, et al. Remote Ischemic Preconditioning Correction in ADMA-Like Gestosis Model. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2014; 5(5): 1095–8 (in Russian).
(check this in PDF content)
74
Gureev VV, Zhilinkova LA, Stupakova EG. Nikorandil tetrahydrobiopterin and resveratrol correction of endothelial dysfunction in modeling experimental preeclampsia. Fundamentalnye issledovaniya 2015; (1): 58–62 (in Russian).
(check this in PDF content)
75
Gureev VV, Alekhin SA, Dolzhikov AA, Mostovoy AS. Correction of ADMA-like preeclampsia in the experiment. Kursk scientific-practical bulletin «Chelovek i ego zdorovie» 2012; (1): 14–9 (in Russian). AUTHORS Federal State Autonomous Educational Institution of Higher Professional Education «Belgorod State National Research University»,
(check this in PDF content)